Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/2000
10/31/2000US6140068 Compositions of the present invention are based on the discovery that peptides containing the amino acid sequence phsrn promote wound healing
10/31/2000US6140064 Identifying ligands, and inhibitors (e.g., antagonists) or promoters (e.g., agonists) of receptor function, including methods in which host cells comprising a nucleic acid encoding a cxcr3 or variant thereof are used in an assay to identify
10/31/2000US6140061 Response regulator
10/31/2000US6140059 Methods for the obtention of human immunodeficiency virsus Type 1 envelope glycoproteins in native and oligomeric form employing recombinant chimeric antigens containing collagenase recognition sites.
10/31/2000US6140058 Activation of p53 protein
10/31/2000US6140056 Novel nucleic acid molecules and proteins referred herein as myocardium secreted protein-18 (?msp-18?) molecules; useful as modulating agents in regulating a variety of cellular processes in the cardiovascular system
10/31/2000US6140052 Diagnosing and treating cancers by determining the presence or absence in a cell of wild-type adenomatous polyposis coli (apc) or a wild-type downstream protein in the apc transcription regulatory pathway
10/31/2000US6140043 Pharmaceutical composition comprising a protein, peptide or a functionally equivalent molecule
10/31/2000US6139882 Drugs, foods, beverages, animal feed
10/31/2000US6139869 Human monoclonal antibody specifically binding to surface antigen of cancer cell membrane
10/31/2000US6139862 Pharmaceutical dipeptide compositions and methods of use thereof
10/31/2000US6139860 Method of stimulating cilia
10/31/2000US6139856 Composition useful for providing one-step surgical preparation and drape
10/31/2000US6139846 Protein D- an IGD-binding protein of haemophilus influenzae
10/31/2000US6139845 Treating catecholamine secreting tumor by administering a botulinum toxin
10/31/2000US6139841 Activating immune response in an individual for treatment or prevention of cancer
10/31/2000US6139839 Administering to warm-blooded animal an effective amount of an immunotherapy agent that binds to and inhibits the growth-regulating activity of chorionic gonadotropin-like growth-regulating protein of infectious microorganism
10/31/2000US6139838 Tissue plasminogen activator medicinal composition
10/31/2000US6139837 ATP-dependent RNA helicase protein
10/31/2000US6139836 Lysed and partially lysed red blood cells are concentrated prior to introduction of biologically active agent; resultant carrier red blood cells are stable for extended period of time and can be used for systemic or targeted delivery of drugs
10/31/2000US6139835 Homologous recombination for allogeneic donor cells
10/31/2000US6139832 Leukocyte adhesion inhibitor-1 (LAI-1) Polypeptides
10/31/2000US6138680 Method for destroying retinal pigment epithelial cells
10/31/2000CA2197684C Human-murine chimeric antibodies against respiratory syncytial virus
10/31/2000CA2185112C Humanized monoclonal antibodies against human interleukin-4
10/31/2000CA2142879C Method of treating cell damage or depletion
10/31/2000CA2116535C A method for treatment of patients with chronic liver disease
10/31/2000CA2009403C A packaging defective hiv provirus, cell lines, and uses thereof
10/31/2000CA1341131C Human nerve growth factor
10/28/2000CA2300229A1 Physiologically-active health foods
10/27/2000CA2307108A1 Process for production of mammalian cell lines, produced cell lines and their uses
10/27/2000CA2307104A1 Human myoblast cell lines and their uses
10/26/2000WO2000063702A1 Peptide epitopes recognized by disease promoting cd4+ t lymphocytes
10/26/2000WO2000063689A1 Detecting and suppressing malignancy based on expression of spleen tyrosine kinase (syk)
10/26/2000WO2000063434A1 MinK-RELATED GENES, FORMATION OF POTASSIUM CHANNELS AND ASSOCIATION WITH CARDIAC ARRHYTHMIA
10/26/2000WO2000063405A1 Vectors containing a gene coding for cd40 and/or cd40l under the control of a cytokine-inducible promoter, methods for their production and uses thereof
10/26/2000WO2000063395A1 Nucleic acids encoding cd40/cd40l chimeric polypeptides, methods for their production and uses thereof
10/26/2000WO2000063392A1 Novel tyrosine phosphatase
10/26/2000WO2000063384A1 Streptokinase fragments and their use for inhibiting cell death
10/26/2000WO2000063381A1 Mammalian protein with putative function in signal transduction
10/26/2000WO2000063380A1 Vascular endothelial cell growth factor variants and uses thereof
10/26/2000WO2000063379A2 The p2x3 receptor, methods of altering p2x3 receptor activity and uses thereof
10/26/2000WO2000063378A2 Zalpha13: a human secreted protein
10/26/2000WO2000063377A1 Adipocyte complement related protein homolog zacrp3
10/26/2000WO2000063376A1 Adipocyte complement related protein homolog zacrp2
10/26/2000WO2000063374A1 Synthetic transmembrane components
10/26/2000WO2000063372A1 Synthetic signalling molecules
10/26/2000WO2000063370A2 Nucleic acids coding for novel truncated cart proteins, corresponding truncated cart polypeptides and their use for therapeutic and diagnostic purposes
10/26/2000WO2000063368A1 Recombinant protein uk114 and its use in therapy and diagnostics
10/26/2000WO2000063367A1 A novel family of beta sub-unit proteins from a voltage-gated sodium channel, nucleic acids encoding them and therapeutic or diagnostic uses thereof
10/26/2000WO2000063364A2 Methods and compositions for inhibiting the function of polynucleotide sequences
10/26/2000WO2000063357A2 Methods and compositions for modulating ciliary neurotrophic factor activity
10/26/2000WO2000063352A2 Human homologues of fused gene
10/26/2000WO2000063351A2 Carbohydrate-modifying enzymes
10/26/2000WO2000063349A1 Human hac3
10/26/2000WO2000063345A1 PSEUDOMYCIN PRODUCTION BY $i(PSEUDOMONAS SYRINGAE)
10/26/2000WO2000063251A1 Composition and method for modulating dendritic cell-t cell interaction
10/26/2000WO2000063249A1 Polypeptides derived from endostatin exhibiting antiangiogenic activity
10/26/2000WO2000063248A2 Highly purified gonadotropin compositions and process for preparing them
10/26/2000WO2000063247A2 Osteopontin-derived chemotactic and inhibitory agents and uses therefor
10/26/2000WO2000063246A2 Compounds and methods for modulating beta-catenin mediated gene expression
10/26/2000WO2000063245A2 Variant of the plasmodium merozoite surface protein (msp-1) and vaccine comprising said variant
10/26/2000WO2000063241A2 Methods and compositions for modulating an immune response
10/26/2000WO2000063240A1 ANTIFUNGAL AGENTS ISOLATED FROM $i(PSEUDOMONAS SYRINGAE)
10/26/2000WO2000063239A1 Novel antifungal compounds
10/26/2000WO2000063237A2 Pseudomycin analogs
10/26/2000WO2000063236A2 Adhesion modulatory peptides and methods for use
10/26/2000WO2000063234A2 Pyrrolidincarbonylamino cyclic disulfides as vcam-vla4 antagonists
10/26/2000WO2000063230A2 49 human secreted proteins
10/26/2000WO2000063227A1 A splicing variant of human membrane-type matrix metalloproteinase-5 (mt-mmp5-l)
10/26/2000WO2000063226A1 Interleukin-1 homologue, il-1h4
10/26/2000WO2000063221A2 Galectin 11
10/26/2000WO2000062862A1 Method of prophylaxis and treatment of diabetes
10/26/2000WO2000062813A2 Cationic peg-lipids and methods of use
10/26/2000WO2000062809A1 Proliferation inhibitor for androgen-independent tumor
10/26/2000WO2000062807A1 Diagnosis and treatment of neuroectodermal tumors
10/26/2000WO2000062805A1 A method of reversing thymic atrophy
10/26/2000WO2000062804A2 Identification of sortase gene
10/26/2000WO2000062799A1 Hcv combination therapy, containing ribavirin in association with antioxidants
10/26/2000WO2000062798A2 Angiogenic growth factors for treatment of peripheral neuropathy
10/26/2000WO2000062797A1 Remedies for autonomic neuropathy
10/26/2000WO2000062796A1 Agents for ameliorating pancreatic function disorder
10/26/2000WO2000062795A2 UTEROGLOBIN IN THE TREATMENT OF IgA MEDIATED AUTOIMMUNE DISORDERS
10/26/2000WO2000062794A1 A non-immunosuppressive process for inducing acceptance of incompatible transplants
10/26/2000WO2000062793A2 Pseudomycin antifungal compositions and methods for their use
10/26/2000WO2000062791A1 D-form polypeptide which induces immune tolerance and methods of use
10/26/2000WO2000062790A2 Soluble tumor necrosis factor receptor treatment of medical disorders
10/26/2000WO2000062789A1 Peptide extract of lupine and pharmaceutical or cosmetic or nutritional composition comprising same
10/26/2000WO2000062781A1 Medicaments containing inhibitors of cell-volume regulated human kinase h-sgk
10/26/2000WO2000062780A1 Use of glucosylceramide synthesis inhibitors in therapy
10/26/2000WO2000062774A1 Methods of treating clinical diseases with isoflavones
10/26/2000WO2000062773A1 Composition comprising a carnitine and glutathione, useful to increase the absorption of glutathione and synergize its effects
10/26/2000WO2000062764A1 Gum pad for delivery of medication to mucosal tissues
10/26/2000WO2000062761A1 Process for microencapsulation of water soluble substances
10/26/2000WO2000062759A1 Dry, mouldable drug formulation
10/26/2000WO2000062758A1 A method for improving the half-life of soluble viral-specific ligands on mucosal membranes
10/26/2000WO2000062744A2 Skin care compositions containing combination of skin care actives
10/26/2000WO2000062743A2 Skin care compositions containing combination of skin care actives
10/26/2000WO2000062742A2 Methods for regulating the condition of mammalian keratinous tissue
10/26/2000WO2000062740A2 Skin care compositions containing combination of skin care actives
1 ... 2331 2332 2333 2334 2335 2336 2337 2338 2339 2340 2341 2342 2343 2344 2345 2346 2347 2348 2349 2350 2351 ... 3163